Saint Marys Regional Medical Center Chemical Dependency Service
-
Services:
- Smoking not permitted
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Female
- Male
- General Hospital (including VA hospital)
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Lofexidine or Clonidine detoxification
- Buprenorphine detoxification
- Social skills development
- Early intervention for HIV
- Integrated primary care services
- Domestic violence services, including family or partner
- Suicide prevention services
- Mental health services
- Assistance with obtaining social services
- Housing services
- Mentoring/peer support
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Testing for Hepatitis B (HBV)
- Breathalyzer or blood alcohol testing
- Metabolic syndrome monitoring
- HIV testing
- STD testing
- Discharge Planning
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- Children/Adolescents
- Medicare
- Cash or self-payment
- Medicaid
- Federal military insurance (e.g., TRICARE)
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Sign language services for the deaf and hard of hearing
- Private non-profit organization
- In-network prescribing entity
- Vaping not permitted
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
- Alcohol Detoxification
- Medication routinely used during detoxification
- Benzodiazepines Detoxification
- Opioids detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- State Substance use treatment agency
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Screening for tobacco use
- Screening for mental disorders
- Interim services for clients
- Screening for substance use
- Complete medical history/physical exam
- Trauma-related counseling
- Contingency management/motivational incentives
- Motivational interviewing
- Substance use disorder counseling
- Brief intervention
- Relapse prevention
- Anger management
- Cognitive behavioral therapy
- Payment assistance (check with facility for details)
- Medications for pre-exposure to prophylaxis
- Medications for Hepatitis C treatment
- Naltrexone (oral)
- Buprenorphine with naloxone
- Medication for mental disorders
- Clonidine
- Acamprosate (Campral®)
- Disulfiram
- Lofexidine
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Buprenorphine without naloxone
- Naltrexone (extended-release, injectable)
- Medications for HIV treatment
- Hospital inpatient detoxification
- Hospital inpatient/24-hour hospital inpatient
- Hospital inpatient treatment
- Detoxification
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Marital/couples counseling
- Substance use disorder education
- Individual counseling
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Group counseling
Facility Smoking Policy
Opioid Medications used in Treatment
Gender Accepted
Hospitals
Type of Opioid Treatment
Ancillary Services
Recovery Support Services
Testing
Transitional Services
Age Groups Accepted
Payment/Insurance/Funding Accepted
Type of Alcohol Use Disorder Treatment
Language Services
Facility Operation (e.g., Private, Public)
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Vaping Policy
Medical Services
Detoxification (medical withdrawal) Services
License/Certification/Accreditation
Assessment/Pre-treatment
Treatment Approaches
Payment Assistance Available
Pharmacotherapies
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Care
Education and Counseling Services






